330 related articles for article (PubMed ID: 15326195)
1. Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer.
Hotta K; Matsuo K; Ueoka H; Kiura K; Tabata M; Tanimoto M
J Clin Oncol; 2004 Oct; 22(19):3852-9. PubMed ID: 15326195
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
Thigpen T; Vance R; Puneky L; Khansur T
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of two platinum combinations in patients with advanced non-small cell lung cancer: a preliminary report. European Organization for the Research and Treatment of Cancer--Lung Cancer Working Party.
Klastersky J; Sculier JP; Dabouis G; Bureau G; Libert P; Ravez P; Vandermoten G; Thiriaux J; Lecomte J; Cordier R
Semin Oncol; 1990 Feb; 17(1 Suppl 2):20-4. PubMed ID: 2154855
[TBL] [Abstract][Full Text] [Related]
4. Single-agent versus combination chemotherapy in advanced non-small cell lung cancer: a meta-analysis and the Cancer and Leukemia Group B randomized trial.
Lilenbaum RC; List M; Desch C
Semin Oncol; 1999 Oct; 26(5 Suppl 15):52-4. PubMed ID: 10566612
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group.
BMJ; 1995 Oct; 311(7010):899-909. PubMed ID: 7580546
[TBL] [Abstract][Full Text] [Related]
6. Carboplatin in non-small cell lung cancer: review of the Eastern Cooperative Oncology Group trial and comparison with other carboplatin trials.
Bonomi P
Semin Oncol; 1991 Feb; 18(1 Suppl 2):2-7. PubMed ID: 1846979
[TBL] [Abstract][Full Text] [Related]
7. Triplet chemotherapy combinations with new agents: is there a rationale?
Bunn PA
Semin Oncol; 1998 Aug; 25(4 Suppl 9):55-61. PubMed ID: 9728586
[TBL] [Abstract][Full Text] [Related]
8. The future beyond platinum for the treatment of advanced non-small cell lung cancer.
Dragnev KH; Rigas JR
Semin Oncol; 1999 Oct; 26(5 Suppl 16):73-6. PubMed ID: 10585012
[TBL] [Abstract][Full Text] [Related]
9. [Recent progress in chemotherapy for advanced lung cancer].
Negoro S; Fukuoka M
Gan To Kagaku Ryoho; 1995 Mar; 22(4):451-60. PubMed ID: 7887637
[TBL] [Abstract][Full Text] [Related]
10. Review of paclitaxel/carboplatin in advanced non-small cell lung cancer.
Bonomi P
Semin Oncol; 1999 Feb; 26(1 Suppl 2):55-9. PubMed ID: 10190784
[TBL] [Abstract][Full Text] [Related]
11. Lung cancer.
Hansen HH; Rørth M
Cancer Chemother Biol Response Modif; 1999; 18():336-56. PubMed ID: 10800491
[TBL] [Abstract][Full Text] [Related]
12. [Chemotherapy for lung cancer].
Fujiwara K; Eguchi K
Nihon Rinsho; 2000 May; 58(5):1087-92. PubMed ID: 10824554
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic factors in advanced stage non-small cell bronchial cancer: experiences of the European Lung Cancer Working Party].
Sculier JP; Paesmans M; Libert P; Bureau G; Dabouis G; Thiriaux J; Michel J; Van Cutsem O; Schmerber J; Giner V; Berchier MC; Mommen P; Sergysels R; Klastersky J
Rev Mal Respir; 1997 Dec; 14(6):445-9. PubMed ID: 9496602
[TBL] [Abstract][Full Text] [Related]
14. The European Organization for Research and Treatment of Cancer experience with teniposide: preliminary results of a randomized study in non-small cell lung cancer.
Giaccone G; Splinter TA; Kirkpatrick A; Dalesio O; van Zandwijk N; McVie JG
Semin Oncol; 1992 Apr; 19(2 Suppl 6):98-102. PubMed ID: 1329231
[TBL] [Abstract][Full Text] [Related]
15. Role of carboplatin in ovarian cancer. Current results and thoughts for the future.
Ozols RF
Acta Obstet Gynecol Scand Suppl; 1992; 155():75-7. PubMed ID: 1502894
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy for unresectable non-small cell lung cancer.
Johnson DH
Semin Oncol; 1990 Aug; 17(4 Suppl 7):20-9. PubMed ID: 2166346
[TBL] [Abstract][Full Text] [Related]
17. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
Bonetti A; Apostoli P; Zaninelli M; Pavanel F; Colombatti M; Cetto GL; Franceschi T; Sperotto L; Leone R
Clin Cancer Res; 1996 Nov; 2(11):1829-35. PubMed ID: 9816137
[TBL] [Abstract][Full Text] [Related]
18. Multimodality management of regionally advanced non-small-cell lung cancer.
Belani CP
Semin Oncol; 1993 Aug; 20(4):302-14. PubMed ID: 8393590
[No Abstract] [Full Text] [Related]
19. The results of a quantitative overview of chemotherapy in advanced ovarian cancer: what can we learn?
Stewart LA; Parmar MK
Bull Cancer; 1993 Feb; 80(2):146-51. PubMed ID: 8173166
[TBL] [Abstract][Full Text] [Related]
20. The future role of carboplatin.
Ruckdeschel JC
Semin Oncol; 1994 Oct; 21(5 Suppl 12):114-8. PubMed ID: 7992063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
